Vext Science, Inc. (CNSX: VEXT)
Health Care · Pharmaceuticals · US
CA$0.26
+15.56% today · -25.7% 1Y
Vext Science, Inc. (CNSX: VEXT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $45.14M and employs 173 people.
Over the last twelve months the share price has lost 25.7%, trading between 0.19 and 0.40.
Tweenvest scores Vext Science, Inc. across four factors: quality 60/100, value 53/100, growth 75/100. Its strongest factor is growth.
VEXT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.14M
- Revenue (TTM)
- $50.68M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- CA$0.40
- 52-week low
- CA$0.19
- Avg volume (3M)
- —
- Shares outstanding
- 247.71M
- Employees
- 173
- Next earnings
- —
About Vext Science, Inc.
Vext Science, Inc., through its various subsidiaries, operates as a comprehensive agricultural technology, services, and property management company within the United States cannabis sector. Its operations span the entire product lifecycle, from cultivating and extracting to manufacturing and distributing THC and CBD vape cartridges, concentrates, and edibles. The company also manages retail dispensaries and conducts wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Expanding its edible range, Vext Science offers various THC-infused items under the Vapen Kitchens brand, including Vapen Clear products, chocolate bars, syrups, snacks, candies, and gummies. Incorporated in 2015, the company was formerly known as Vapen MJ Ventures Corporation, adopting its current name, Vext Science, Inc., in November 2019. Its headquarters are located in Phoenix, Arizona.
- ISIN
- CA9255401064
- Founded
- 2015
- Listed since
- May 13, 2019
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ADBiotech Co., Ltd.KOSDAQ: A179530 | $45.91M | ₩2,290.00 | +11.44% |
| BioStem Technologies, Inc.NasdaqCM: BSEM | $45.90M | $2.47 | -9.52% |
| Pharmedic Pharmaceutical Medicinal Joint Stock CompanyHNX: PMC | $45.63M | ₫127,000.00 | +1.68% |
| Trident Lifeline LimitedBSE: 543616 | $45.62M | Rs370.00 | -1.69% |
| Yuyu Pharma, Inc.KOSE: A000220 | $44.98M | ₩3,840.00 | +1.59% |
| Oncoinvent ASAOB: ONCIN | $44.84M | Nkr69.40 | -0.86% |
| Advagene Biopharma Co., Ltd.TPEX: 6709 | $44.48M | NT$23.95 | -0.21% |
| Arovella Therapeutics LimitedASX: ALA | $43.87M | AU$0.05 | +10.64% |
Figures last refreshed Oct 11, 2026.